Growth Metrics

Lexicon Pharmaceuticals (LXRX) Total Debt Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 5.94%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 103.99%
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 0.07%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -
10 Lexicon Pharmaceuticals 872.52 Mn 701.87 Mn 20.99 Mn -50.66%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -50.66%
Dec 31, 2025 -46.16%
Sep 30, 2025 -43.44%
Jun 30, 2025 -43.61%
Mar 31, 2025 0.80%
Dec 31, 2024 0.79%
Sep 30, 2024 0.63%
Jun 30, 2024 0.74%
Mar 31, 2024 104.52%
Dec 31, 2023 104.84%
Sep 30, 2023 317.36%
Jun 30, 2023 317.98%
Mar 31, 2023 108.05%
Sep 30, 2022 103.40%
Jun 30, 2022 102.41%
Mar 31, 2022 101.35%
Sep 30, 2021 -42.46%
Jun 30, 2021 -95.24%
Mar 31, 2021 -95.25%
Dec 31, 2020 -95.25%
Sep 30, 2020 -91.71%
Jun 30, 2020 0.08%
Mar 31, 2020 0.08%
Dec 31, 2019 0.07%
Sep 30, 2019 0.07%
Jun 30, 2019 -0.01%
Mar 31, 2019 -0.15%
Dec 31, 2018 -0.27%
Sep 30, 2018 144.59%
Jun 30, 2018 143.78%
Mar 31, 2018 142.92%
Dec 31, 2017 142.17%
Sep 30, 2017 -1.65%
Jun 30, 2017 -1.62%
Mar 31, 2017 -1.51%
Dec 31, 2016 -1.45%
Sep 30, 2016 -4.19%
Jun 30, 2016 -4.27%
Mar 31, 2016 -4.33%
Dec 31, 2015 -4.39%
Sep 30, 2015 415.74%
Jun 30, 2015 407.44%
Mar 31, 2015 399.66%
Dec 31, 2014 392.15%
Sep 30, 2014 -7.52%
Jun 30, 2014 -7.23%
Mar 31, 2014 -6.97%
Dec 31, 2013 -6.71%
Sep 30, 2013 -6.47%
Jun 30, 2013 -6.24%
Mar 31, 2013 -6.02%
Dec 31, 2012 -5.80%
Sep 30, 2012 -5.60%
Jun 30, 2012 -5.40%
Dec 31, 2011 -12.60%